MedTrace Logo

Effects Of Vacuum Controlled Static Versus Vacuum Controlled Dynamic Dry Cupping On Pain, Range Of Motion And Disability Among Patients With Chronic Low Back Pain

NCT07702617 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2026-07-22

No results posted yet for this study

Summary

This randomized controlled clinical trial aims to compare the effects of vacuum-controlled static dry cupping and vacuum-controlled dynamic dry cupping on pain intensity, lumbar range of motion, and functional disability in patients with chronic low back pain. Participants will be randomly assigned to two groups receiving either static or dynamic dry cupping along with conventional treatment. The outcomes will be assessed to determine which cupping technique is more effective in improving pain, mobility, and functional ability in individuals with chronic low back pain.

\[Time Frame: Measured at baseline (pre-intervention) and after 6 weeks (post-intervention completion).

Conditions

  • Chronic Low-back Pain (cLBP)

Interventions

OTHER

Vacuum-Controlled Static Dry Cupping

Vacuum-controlled static dry cupping will be applied to the lumbar region of patients with chronic low back pain. Cups will be placed on the affected area and kept stationary for approximately 10 minutes to create negative pressure, aiming to improve blood circulation, reduce pain, and relieve muscle tension.

OTHER

Vacuum-Controlled Dynamic Dry Cupping

Vacuum-controlled dynamic dry cupping will be applied to the lumbar region. After creating negative pressure, the cups will be gently moved over the skin to mobilize soft tissues, enhance circulation, reduce pain, and improve lumbar mobility in patients with chronic low back pain.

Sponsors & Collaborators

  • Lahore University of Biological and Applied Sciences

    lead OTHER

Principal Investigators

  • Shoaib Waqas · Lahore University of Biological and Applied Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-01
Primary Completion
2026-10-30
Completion
2026-11-30

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07702617 on ClinicalTrials.gov